Skip to main content
. 2020 May 18;105(7):e2346–e2357. doi: 10.1210/clinem/dgaa246

Figure 2.

Figure 2.

Overall survival as a function of: A, thyroid cancer histology or B, line of multikinase inhibitor (MKI) therapy.